增殖性玻璃体视网膜病变
医学
心理干预
眼科
重症监护医学
验光服务
玻璃体切除术
视力
护理部
作者
Wilson X. Wang,Maggie Xing,Rajendra S. Apte
出处
期刊:JAMA Ophthalmology
[American Medical Association]
日期:2024-05-23
卷期号:142 (7): 669-669
标识
DOI:10.1001/jamaophthalmol.2024.1093
摘要
Clinical Question What is the efficacy of pharmacologic interventions in preventing proliferative vitreoretinopathy? Bottom Line There is limited high-quality evidence to support currently available pharmacological options for prevention of proliferative vitreoretinopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI